Acute Vaginal Candidiasis: A review of treatment guidelines and Siriraj experience

Main Article Content

Chenchit Chayachinda
Thanapa Rekhawasin
Manopchai Thamkhantho
Payaow Aneklap


Acute vaginal candidiasis (VC) is a leading cause of abnormal vaginal discharge at gynecologic clinics. The most common causative organism is Candida albicans, which is one of the vaginal normal flora. Therefore, VC is not considered as being a sexually-transmitted disease (STD). Host factors such as a disturbance of vaginal ecosystem, a prolonged use of antibiotics and individual hormonal effect appear to precipitate the condition. Although symptoms and signs of VC are unique, the diagnosis also requires a basic tool like a microscope. Azole antifungals are recommended as the first-line treatment in all guidelines. However, lifestyle modification is apparently as important. As the Siriraj Female STD Clinic (Clinic 309) has been taking of this group of patients and has conducted some clinical trials on this issue, we would like to review current treatment guidelines of VC and to share some of our experience.


Download data is not yet available.

Article Details

Special Article


Chayachinda C, Thamkhantho M, Chalermchockcharoenkit A, Neungton C, Thipmontree W. Characteristics of Clients at the Siriraj Female STD Clinic during 2011- 2015. Siriraj Med Bull 2018;11:182-9.

Sobel JD. Vulvovaginal candidosis. Lancet 2007;369:1961-71.

Workowski K, Bolan G. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64;1-137

British Association for Sexual Health and HIV. British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2019)2019. Accessed 28 July 2020. Available from:

Zeng X, Zhang Y, Zhang T, Xue Y, Xu H, An R. Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi’an: A cross-sectional study. Biomed Res Int 2018;2018:9703754.

Donders G, van Straeten D, Hooft P, de Wet G. Detection of Candida cell forms in Pap smear during pregnancy. Eur J Obstet Gynecol Reprod Biol 1992;43:13-8.

Og A, Oe O, To A. Sensitivity of a papanicolaou smear in the diagnosis of Candida albicans infection of the cervix. N Am J Med Sci 2010;2:97-9.

Mendling W, Atef El Shazly M, Zhang L. Clotrimazole for vulvovaginal candidiasis: more than 45 years of clinical experience. Pharmaceuticals 2020;13:274.

Haddad P, Anderson I. Anti-psychotic related QTc prolongation, torsades de pointes and sudden death. Drugs 2002;62:1649-71.

Yap Y, Camm A. Drug induced QT prolongation and torsades de pointes. Heart 2003;89:1363-72.

Taylor D. Antipsychotics and QT prolongation. Acta Psychiatr Scand 2003;107:85-95.

Australian Sexual Health Alliance. Candidiasis. Australian STI management guidelines for use in primary care [Internet]. 2018 12 March 2021. Available from:

Sherrard J, Wilson J, Donders G, Mendling W, Jensen J. 2018 European (IUSTI/WHO) International Union against Sexually Transmitted Infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDs 2018;29:1258-72.

Roongpisuthipong A, Bhiraleus P, Pattanapanich P, Bhadrakom C, Chaisilwattana P, Sukroongreung S. Evaluation of miconazole in vaginal gelatin capsules as a topical treatment for vaginal candidosis. J Med Assoc Thai 1985;68:126-31.

Chaisilwattana P, Bhiraleus P, Patanapanich P, Bhadrakom C, Roongpisuthipong A, Sukroongreung S. Treatment of vaginal candidosis with oral ketoconazole. J Med Assoc Thai 1986;69:373-7.

Chaisilwattana P, Roongpisuthipong A, Bhiraleus P, Chaiprasert A. Three-day therapy of vulvovaginal candidosis with econazole. J Med Assoc Thai 1987;70:497-500.

Roongpisuthipong A, Sentrakul P, Bhiraleus P, Dusitsin N, Sukroongreung S, Pupaibul K. Itraconazole in the treatment of acute vaginal candidosis. J Med Assoc Thai 1992;75:30-4.

Roongpisuthipong A, Chalermchockcharoenkit A, Sirimai K, Wanitpongpan P, Jaishuen A, Foongladda S, et al. Safety and efficacy of a new imidazole fungicide, Sertaconazole, in the treatment of fungal vulvo-vaginitis: a comparative study using fluconazole and clotrimazole. Asian Biomedicine 2010;4:443-8.

Thamkhantho M, Chayachinda C. Vaginal tablets of dequalinium chloride 10 mg versus clotrimazole 100 mg for vaginal candidiasis: a double-blind, randomized study. Arch Gynecol Obstet 2021;303:151-60.

Cotch M, Hillier S, Gibbs R, Eschenbach D. Epidemiology and outcomes associated with moderate to heavy Candida colonisation during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1998;178:374-80.